Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older at the time of enrollment
- People who have signed a consent form agreeing to take part in the study
- People with Stage III or Stage IV follicular lymphoma who have already received at least one round of systemic (whole-body) treatment for their condition
- People whose lymphoma has come back or stopped responding to their first-line treatment. This includes: tumors that shrank by less than 50%, or that got worse after 4 cycles of standard chemotherapy; cancer that responded to treatment but came back within 24 months; or cancer that has relapsed two or more times and meets one of the above conditions
- People who are receiving treatment with a combination of two specific medications — obinutuzumab and lenalidomide (confirm with trial site for exact treatment conditions)
Who may not be able to join:
- People who are currently taking part in, or planning to take part in, another clinical trial that involves a medical intervention
- People who, for any other reason, the trial doctor considers unsuitable for the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shuhua Yi, Dr, Institute of Hematology & Blood Diseases Hospital, Chinese
Phone: 86-22-23909106
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
overall response rate（ORR）
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.